Elizabeth Hamelink

841 total citations
16 papers, 508 citations indexed

About

Elizabeth Hamelink is a scholar working on Molecular Biology, Computational Theory and Mathematics and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Elizabeth Hamelink has authored 16 papers receiving a total of 508 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Computational Theory and Mathematics and 8 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Elizabeth Hamelink's work include Computational Drug Discovery Methods (8 papers), Malaria Research and Control (8 papers) and HIV/AIDS drug development and treatment (5 papers). Elizabeth Hamelink is often cited by papers focused on Computational Drug Discovery Methods (8 papers), Malaria Research and Control (8 papers) and HIV/AIDS drug development and treatment (5 papers). Elizabeth Hamelink collaborates with scholars based in Sweden, United States and Greece. Elizabeth Hamelink's co-authors include Bertil Samuelsson, Anders Hallberg, Lotta Vrang, Michael J. Blackman, Johan Hultén, Karolina Ersmark, Johan Åqvist, Åsa Rosenquist, Ingemar Kvarnström and Wesley Schaal and has published in prestigious journals such as Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry and Bioorganic & Medicinal Chemistry Letters.

In The Last Decade

Elizabeth Hamelink

16 papers receiving 500 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elizabeth Hamelink Sweden 14 227 203 195 180 70 16 508
Solange Meyer Switzerland 15 216 1.0× 270 1.3× 191 1.0× 225 1.3× 72 1.0× 19 682
Falgun Shah United States 18 277 1.2× 133 0.7× 254 1.3× 131 0.7× 74 1.1× 22 712
Christine Latour France 17 152 0.7× 289 1.4× 88 0.5× 331 1.8× 59 0.8× 23 747
Soumendranath Bhakat South Africa 14 334 1.5× 120 0.6× 202 1.0× 106 0.6× 120 1.7× 32 621
Michael H. L. Wong United Kingdom 7 197 0.9× 225 1.1× 85 0.4× 79 0.4× 49 0.7× 7 478
Jérôme Cazelles France 10 165 0.7× 480 2.4× 207 1.1× 253 1.4× 79 1.1× 10 676
Abraham Thomas India 16 183 0.8× 198 1.0× 84 0.4× 385 2.1× 24 0.3× 30 697
James M. Grace United States 8 79 0.3× 241 1.2× 129 0.7× 59 0.3× 53 0.8× 12 429
Aloysius T. Nchinda South Africa 13 256 1.1× 82 0.4× 104 0.5× 223 1.2× 53 0.8× 27 557
Corinna Grisostomi Switzerland 12 239 1.1× 95 0.5× 74 0.4× 123 0.7× 22 0.3× 13 424

Countries citing papers authored by Elizabeth Hamelink

Since Specialization
Citations

This map shows the geographic impact of Elizabeth Hamelink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth Hamelink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth Hamelink more than expected).

Fields of papers citing papers by Elizabeth Hamelink

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth Hamelink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth Hamelink. The network helps show where Elizabeth Hamelink may publish in the future.

Co-authorship network of co-authors of Elizabeth Hamelink

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth Hamelink. A scholar is included among the top collaborators of Elizabeth Hamelink based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth Hamelink. Elizabeth Hamelink is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Koukoulitsa, Catherine, Róbert Csonka, Xanthippi Alexi, et al.. (2015). Biological and computational evaluation of resveratrol inhibitors against Alzheimer’s disease. Journal of Enzyme Inhibition and Medicinal Chemistry. 31(1). 67–77. 32 indexed citations
2.
Sund, Christian, Oscar Belda, Neera Borkakoti, et al.. (2012). Design and synthesis of potent hydroxyethylamine (HEA) BACE-1 inhibitors carrying prime side 4,5,6,7-tetrahydrobenzazole and 4,5,6,7-tetrahydropyridinoazole templates. Bioorganic & Medicinal Chemistry Letters. 22(21). 6721–6727. 8 indexed citations
3.
Sund, Christian, Oscar Belda, Christer Sahlberg, et al.. (2010). Design and synthesis of potent macrocyclic renin inhibitors. Bioorganic & Medicinal Chemistry Letters. 21(1). 358–362. 15 indexed citations
4.
Bäck, Marcus, Per-Ola Johansson, Ingemar Kvarnström, et al.. (2007). Novel potent macrocyclic inhibitors of the hepatitis C virus NS3 protease: Use of cyclopentane and cyclopentene P2-motifs. Bioorganic & Medicinal Chemistry. 15(22). 7184–7202. 19 indexed citations
5.
Kvarnström, Ingemar, Lotta Vrang, Elizabeth Hamelink, et al.. (2006). Synthesis of novel potent hepatitis C virus NS3 protease inhibitors: Discovery of 4-hydroxy-cyclopent-2-ene-1,2-dicarboxylic acid as a N-acyl-l-hydroxyproline bioisostere. Bioorganic & Medicinal Chemistry. 15(2). 827–838. 8 indexed citations
6.
Johansson, Per-Ola, Marcus Bäck, Ingemar Kvarnström, et al.. (2006). Potent inhibitors of the hepatitis C virus NS3 protease: Use of a novel P2 cyclopentane-derived template. Bioorganic & Medicinal Chemistry. 14(15). 5136–5151. 13 indexed citations
7.
Muthas, Daniel, Yogesh Sabnis, Elizabeth Hamelink, et al.. (2005). Synthesis, biological evaluation, and modeling studies of inhibitors aimed at the malarial proteases plasmepsins I and II. Bioorganic & Medicinal Chemistry. 13(18). 5371–5390. 30 indexed citations
8.
Ersmark, Karolina, Martin Nervall, Elizabeth Hamelink, et al.. (2005). Synthesis of Malarial Plasmepsin Inhibitors and Prediction of Binding Modes by Molecular Dynamics Simulations. Journal of Medicinal Chemistry. 48(19). 6090–6106. 53 indexed citations
9.
Ersmark, Karolina, Martin Nervall, Hugo Gutiérrez‐de‐Terán, et al.. (2005). Macrocyclic inhibitors of the malarial aspartic proteases plasmepsin I, II, and IV. Bioorganic & Medicinal Chemistry. 14(7). 2197–2208. 27 indexed citations
10.
Johansson, Per-Ola, Jimmy Lindberg, Michael J. Blackman, et al.. (2005). Design and Synthesis of Potent Inhibitors of Plasmepsin I and II:  X-ray Crystal Structure of Inhibitor in Complex with Plasmepsin II. Journal of Medicinal Chemistry. 48(13). 4400–4409. 28 indexed citations
11.
Johansson, Per-Ola, Yantao Chen, Michael J. Blackman, et al.. (2004). Design and Synthesis of Potent Inhibitors of the Malaria Aspartyl Proteases Plasmepsin I and II. Use of Solid-Phase Synthesis to Explore Novel Statine Motifs. Journal of Medicinal Chemistry. 47(13). 3353–3366. 36 indexed citations
12.
Oscarson, Stefan, et al.. (2003). New potent C2-Symmetric malaria plasmepsin I and II inhibitors. Bioorganic & Medicinal Chemistry. 11(7). 1235–1246. 25 indexed citations
13.
Schaal, Wesley, et al.. (2003). High-Speed Optimization of Inhibitors of the Malarial Proteases Plasmepsin I and II. Journal of Combinatorial Chemistry. 5(4). 456–464. 49 indexed citations
14.
Kvarnström, Ingemar, Lotta Vrang, Elizabeth Hamelink, et al.. (2003). Solid-phase library synthesis of reversed-statine type inhibitors of the malarial aspartyl proteases plasmepsin I and II. Bioorganic & Medicinal Chemistry. 11(6). 827–841. 14 indexed citations
15.
Ersmark, Karolina, Isabella Feierberg, Sinisa Bjelic, et al.. (2003). Potent Inhibitors of the Plasmodium falciparum Enzymes Plasmepsin I and II Devoid of Cathepsin D Inhibitory Activity. Journal of Medicinal Chemistry. 47(1). 110–122. 85 indexed citations
16.
Hamelink, Elizabeth, Johan Hultén, Mats Wahlgren, et al.. (2003). Design and Synthesis of Plasmepsin I and Plasmepsin II Inhibitors with Activity in Plasmodium falciparum-Infected Cultured Human Erythrocytes. Journal of Medicinal Chemistry. 46(5). 734–746. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Solange Meyer Breakdown of academic impact, for papers by Falgun Shah Breakdown of academic impact, for papers by Christine Latour Breakdown of academic impact, for papers by Soumendranath Bhakat Breakdown of academic impact, for papers by Michael H. L. Wong Breakdown of academic impact, for papers by Jérôme Cazelles Breakdown of academic impact, for papers by Abraham Thomas Breakdown of academic impact, for papers by James M. Grace Breakdown of academic impact, for papers by Aloysius T. Nchinda Breakdown of academic impact, for papers by Corinna Grisostomi
Rankless by CCL
2026